2026 · Poster Presentation · University of Alabama Birmingham · Dermatology
Julie M. Crawford
Publications
43
Total Publications
2025 · Poster Presentation · AbbVie Inc. · Dermatology
Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry
Read more →2025 · Poster Presentation · Northwestern University · Dermatology
Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA
Read more →2025 · Poster Presentation · AbbVie Inc. · Dermatology
Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA
Read more →2025 · Poster Presentation · Methods/Pharmacoepi
Power Vs. Precision When Estimating Risk Differences Using Observational Data? A Case Study From TARGET-IBD
Read more →2025 · Abstract/Manuscript · Northwestern University
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry
Read more →2024 · Poster Presentation · Medical University of South Carolina · Dermatology
Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA
Read more →2024 · Poster Presentation · George Washington University · Dermatology
Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from the TARGET-DERM AD Registry
Read more →2024 · Poster Presentation · Novartis AG · Dermatology
Real-world study of hidradenitis suppurativa: skin lesions and pain are associated with Hurley Stage in TARGET-DERM HS
Read more →2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology
Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort
Read more →2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology
Time to Diagnosis Among Patients with Eosinophilic Esophagitis in the United States
Read more →2024 · Oral Presentation · Novartis AG · Dermatology
Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA
Read more →2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD
Read more →2024 · Poster Presentation · AbbVie Inc. · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry (Fall Clinical 2024)
Read more →2024 · Poster Presentation · AbbVie Inc. · Dermatology
Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry (RAD Winter 2023)
Read more →2023 · Poster Presentation · AbbVie Inc. · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from TARGET-DERM registry (RAD Winter 2023)
Read more →2023 · Poster Presentation · University of Chicago · Gastroenterology
Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD
Read more →2023 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology
Treatment Journey among patients with moderate ulcerative colitis in the United States: TARGET-IBD
Read more →2023 · Abstract/Manuscript · Northwestern University
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
Read more →2023 · Abstract/Manuscript · UCSD
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry
Read more →2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
Read more →2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation
Read more →2022 · Poster Presentation · AbbVie Inc. · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort (RAD 2021)
Read more →2022 · Poster Presentation · University of Chicago · Gastroenterology
The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn's Disease in TARGET IBD
Read more →2022 · Poster Presentation · Bristol Myers Squibb · Gastroenterology
Treatment patterns among moderate-to-severe ulcerative colitis patients in TARGET-IBD
Read more →2022 · Poster Presentation · University of Colorado Anschutz Medical Campus · Gastroenterology
Inflammation on Index Biopsy Predicts Loss of Remission Among Ulcerative Colitis Patients with Endoscopic Remission: a US Cohort Analysis
Read more →2022 · Poster Presentation · Methods/Pharmacoepi
Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with COVID 19
Read more →2022 · Poster Presentation · Methods/Pharmacoepi
Association Between Clinical Outcomes and Patient Characteristics Among Hospitalized Adult Patients with COVID-19
Read more →2022 · Abstract/Manuscript · Northwestern University
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort
Read more →2022 · Abstract/Manuscript · Atrium Health
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
Read more →2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology
Histological Inflammation Predicts Loss of Remission Among Crohn's Patients with Endoscopic Remission: A US Cohort Analysis
Read more →2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology
Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort
Read more →2021 · Poster Presentation · AbbVie Inc. · Gastroenterology
Biologic-naïve Patients with Crohn's Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort
Read more →2021 · Abstract/Manuscript · Atrium Health
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease
Read more →2021 · Abstract/Manuscript · University of Chicago
Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD
Read more →2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Factors Associated with Readmission in the US Following Hospitalization with COVID-19
Read more →2020 · Poster Presentation · Atrium Health · Gastroenterology
Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD
Read more →2020 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States
Read more →2020 · Oral Presentation · Gastroenterology
Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD
Read more →2020 · Poster Presentation · Atrium Health · Gastroenterology
Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)
Read more →2019 · Poster Presentation · University of Pennsylvania · Methods/Pharmacoepi
Factors Associated with Readmission Following COVID-19 Hospitalization
Read more →2018 · Abstract/Manuscript
A Real-World Observational Cohort of Patients with Primary Biliary Cholangitis: TARGET-PBC Study Design and Rationale
Read more →2017 · Poster Presentation · University of Michigan · Hepatology